• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
 
Generic Name:  4-Aminopyridine
Date Designated:  12/14/2005
Orphan Designation:  Treatment chronic functional motor and sensory deficits from Guillain-Barre syndrome
Orphan Designation Status:  Designated
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
Acorda Therapeutics, Inc.
420 Saw Mill River Road
Ardsley, New York 10502
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
-
-